James Robert Janopaul-Naylor

13PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Primary health careMolecular targetsPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 06, 2026
Metastasis-directed radiotherapy (MDRT) for men with de novo, oligometastatic prostate cancer treated with long-term androgen deprivation therapy in the STAMPEDE trial (METANOVA): protocol for a multicentre, phase II randomised controlled trial in the USA.

|Oct 02, 2026
Interpretable machine learning identifies health system levers for survival outcomes of patients with prostate cancer.

|Jul 09, 2026
Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer.

|Aug 20, 2025
Sociodemographic Features, Health Care Costs, and Treatment Implications of Genomic Classifier Testing for Localized Prostate Cancer in the United States.

James R Janopaul-Naylor, Dattatraya Patil, Shreyas Joshi

|Feb 26, 2025
Impact of Systemic and Radiation Therapy on Survival of Primary Central Nervous System Lymphoma.

James Robert Janopaul-Naylor, Jimmy S Patel, Manali Rupji

|Feb 13, 2025
Association Between Medicaid Expansion and Insurance Status, Risk Group, Receipt, and Refusal of Treatment Among Men with Prostate Cancer.

Tej A Patel, Bhav Jain, Edward Christopher Dee

Pageof 3

Frequent Collaborators

2 joint publications

Edward Christopher Dee

2 joint publications

Sagar A Patel

2 joint publications

Sibo Tian

2 joint publications

Himanshu Nagar